Gene editing technology developer Metagenomi advances research from UC Berkeley and has raised a series A co-led by Bayer.

Gene editing technology developer Metagenomi closed its first round since emerging from stealth, with Leaps by Bayer the co-lead.

The videoconferencing platform developer secured $60.4m in a Qi An Xin-led round that came just over 18 months after an investment by Tencent.

IQM Quantum Computers, a Finland-based quantum computing spinout of Aalto University and VTT Technical Research Centre, attracted a €39m ($46m) series A round from investors, including internet group Tencent.

Adagio has raised money in a GV-led series B round that will support the entry of its covid-19 drug candidate into clinical trials early next year.

Based on Aalto University and VTT research, IQM Quantum Computers has lured investors including Tencent to bring its equity and grant funding total to $83.9m.

Julius-Maximilians-University of Würzburg's cancer immunotherapy developer Catalym plans to move its lead asset into the clinic next month.

3M Ventures and NTTVC joined new and existing investors to help the cardiopulmonary virtual care provider boost its overall funding to $92m.

Novartis Venture Fund took part in a series B round closed as Catalym prepares to move its lead cancer immunotherapy asset into the clinic next month.

IQM Quantum Computers has lured investors including Tencent to an ongoing series A round that brought its total equity and grant funding to about $84m.